COVID-19报告与数据系统(CO-RADS)分类及胸部CT受累评分(CT-IS)在COVID-19肺炎中的应用
该回顾性研究纳入土耳其一家三级医院的280例住院COVID-19肺炎患者,由两名放射科医生在不知临床和实验室结果的情况下按CO-RADS分类解读胸部非增强CT,并用CT-IS评估肺部受累。CO-RADS 5组RT-PCR阳性率显著高于其他组(P<0.001),CO-RADS 2组30例RT-PCR均为阴性;总CT-IS在CO-RADS各组间及生存与死亡患者间均有统计学显著差异(P<0.001)。
要点
- CO-RADS 5组RT-PCR阳性结果较其他组有统计学显著差异(P<0.001)。
- CO-RADS 2组30例患者RT-PCR结果均为阴性。
- 总CT-IS在CO-RADS各组间及生存与死亡患者间均有统计学显著差异(P<0.001)。
核心结论
- CO-RADS有助于检测COVID-19,即使RT-PCR检测为阴性。
- CT-IS可作为评估COVID-19肺炎严重程度和范围的影像工具。
研究设计与样本
- 回顾性研究,纳入土耳其一家三级医院的280例住院COVID-19肺炎患者。
- 所有患者接受胸部非增强CT检查。
- 两名放射科医生在不知临床特征和实验室结果的情况下按CO-RADS分类解读所有CT图像。
- 使用CT受累评分(CT-IS)评估COVID-19患者的胸部CT图像。
- 分析CT-IS与COVID-19患者临床结局之间的关系。
诊断标准与关键数值
- 111例(39.6%)患者实时逆转录聚合酶链反应(RT-PCR)结果阳性。
- CO-RADS 5组患者RT-PCR阳性结果较其他组有统计学显著差异(P<0.001)。
- CO-RADS 2组30例患者RT-PCR结果均为阴性。
- CO-RADS 2组平均总CT-IS为3.4 ± 2.8。
- CO-RADS 5组平均总CT-IS为8.2 ± 4.7。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The increasing tendency of chest CT usage throughout the COVID-19 epidemic requires new tools and a systematic scheme for diagnosing and assessing the lung involvement in Coronavirus Disease 2019 (COVID-19). To investigate the use of the COVID-19 Reporting and Data System (CO-RADS) classification and chest CT Involvement Score (CT-IS) in COVID-19 pneumonia.
MATERIAL AND METHODS: This retrospective study enrolled 280 hospitalized patients diagnosed with COVID-19 pneumonia in a tertiary hospital in Turkey. All patients underwent non-contrast CT chest imaging. Two radiologists interpreted all CT images according to CO-RADS classification without knowing the clinical features, laboratory findings. We used CT involvement score (CT-IS) for assessing chest CT images of COVID-19 patients. Also, we examined the relationship between CT-IS and clinical outcomes in COVID-19 patients.
RESULTS: Of the patients, 111(39.6%) had positive real-time reverse transcriptase-polymerase chain reaction (RT-PCR) results. CO-RADS 5 group patients had statistically significant positive RT-PCR results than the other groups (P < 0.001). All of the CO-RADS 2 group patients (30) had negative RT-PCR results. The mean total CT-IS in CO-RADS 2 group was 3.4 ± 2.8. The mean total CT-IS in CO-RADS 5 group was 8.2 ± 4.7. Total CT-IS was statistically significantly different among CO-RADS groups (P < 0.001). The mean total CT-IS was statistically significantly different between survivors and patients died of COVID-19 pneumonia (P < 0.001).
CONCLUSIONS: CO-RADS is useful in detecting COVID-19 disease, even if RT-PCR testing is negative. CT-IS is also helpful as an imaging tool for evaluation of the severity and extent of COVID-19 pneumonia.
引用
- Özel M, Aslan A, Araç S, et al. Use of the COVID-19 Reporting and Data System (CO-RADS) classification and chest computed tomography involvement score (CT-IS) in COVID-19 pneumonia. Radiol Med. 2021. PMID: 33580449. doi:10.1007/s11547-021-01335-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。